McAfee MCPR privilege escalation
CVE-2022-1824

7.9HIGH

Key Information:

Vendor

Mcafee,llc

Status
Mcafee Consumer Product Removal Tool
Vendor
CVE Published:
20 June 2022

What is CVE-2022-1824?

An uncontrolled search path vulnerability in McAfee Consumer Product Removal Tool prior to version 10.4.128 could allow a local attacker to perform a sideloading attack by using a specific file name. This could result in the user gaining elevated permissions and being able to execute arbitrary code as there were insufficient checks on the executable being signed by McAfee.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

McAfee Consumer Product Removal Tool < 10.4.128

References

https://service.mcafee.com/?articleId=TS103318&page=shell...
x_refsource_CONFIRM

CVSS V3.1

Score:
7.9
Severity:
HIGH
Confidentiality:
None
Integrity:
High
Availability:
None
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.